In-vitro activity and killing effect of quinupristin/dalfopristin (RP59500) on nosocomial Staphylococcus aureus and interactions with rifampicin and ciprofloxacin against methicillin-resistant isolates.
暂无分享,去创建一个
[1] P. Appelbaum. Emerging Resistance to Antimicrobial Agents in Gram-Positive Bacteria , 2012, Drugs.
[2] R. Finch. Antibacterial activity of quinupristin/dalfopristin. Rationale for clinical use. , 1996, Drugs.
[3] J. Pechère. Streptogramins. A unique class of antibiotics. , 1996, Drugs.
[4] J. Desnottes,et al. Bactericidal activity and kinetics of RP 59500 in a mouse model of Staphylococcus aureus septicaemia. , 1995, The Journal of antimicrobial chemotherapy.
[5] G. Woods. Antibacterial susceptibility tests : Dilution and disk diffusion methods. , 1995 .
[6] K. Aldridge,et al. In vitro antistaphylococcal activity and testing of RP 59500, a new streptogramin, by two methods , 1992, Antimicrobial Agents and Chemotherapy.
[7] S. Mitsuhashi,et al. Comparative in-vitro activity of RP 59500 against clinical bacterial isolates. , 1992, The Journal of antimicrobial chemotherapy.
[8] J. Hamilton-miller,et al. In-vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic, against gram-positive bacteria. , 1992, The Journal of antimicrobial chemotherapy.
[9] H. Neu,et al. The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination. , 1992, Journal of Antimicrobial Chemotherapy.
[10] S. Miyazaki,et al. The in-vitro activity of RP 59500 against gram-positive cocci. , 1992, The Journal of antimicrobial chemotherapy.
[11] J. Duval,et al. Activity of RP 59500, a new parenteral semisynthetic streptogramin, against staphylococci with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibiotics. , 1992, The Journal of antimicrobial chemotherapy.
[12] J. Verhaegen,et al. Comparative in-vitro activity of RP 59500. , 1992, The Journal of antimicrobial chemotherapy.
[13] H. Larson,et al. Pathology of the Liver , 1980 .